11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Monitoring and manipulating cellular crosstalk during kidney fibrosis inside a 3D in vitro co-culture

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In pharmacological research the development of promising lead compounds requires a detailed understanding of the dynamics of disease progression. However, for many diseases, such as kidney fibrosis, gaining such understanding requires complex real-time, multi-dimensional analysis of diseased and healthy tissue. To allow for such studies with increased throughput we established a dextran hydrogel-based in vitro 3D co-culture as a disease model for kidney fibrosis aimed at the discovery of compounds modulating the epithelial/mesenchymal crosstalk. This platform mimics a simplified pathological renal microenvironment at the interface between tubular epithelial cells and surrounding quiescent fibroblasts. We combined this 3D technology with epithelial reporter cell lines expressing fluorescent biomarkers in order to visualize pathophysiological cell state changes resulting from toxin-mediated chemical injury. Epithelial cell damage onset was robustly detected by image-based monitoring, and injured epithelial spheroids induced myofibroblast differentiation of co-cultured quiescent human fibroblasts. The presented 3D co-culture system therefore provides a unique model system for screening of novel therapeutic molecules capable to interfere and modulate the dialogue between epithelial and mesenchymal cells.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Organoids as an in vitro model of human development and disease.

          The in vitro organoid model is a major technological breakthrough that has already been established as an essential tool in many basic biology and clinical applications. This near-physiological 3D model facilitates an accurate study of a range of in vivo biological processes including tissue renewal, stem cell/niche functions and tissue responses to drugs, mutation or damage. In this Review, we discuss the current achievements, challenges and potential applications of this technique.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nephron organoids derived from human pluripotent stem cells model kidney development and injury

            Kidney cells and tissues derived from human pluripotent stem cells (hPSCs) would enable organ regeneration, disease modeling, and drug screening in vitro. We established an efficient, chemically defined protocol for differentiating hPSCs into multipotent nephron progenitor cells (NPCs) that can form nephron-like structures. By recapitulating metanephric kidney development in vitro, we generate SIX2+SALL1+WT1+PAX2+ NPCs with 90% efficiency within 9 days of differentiation. The NPCs possess the developmental potential of their in vivo counterparts and form PAX8+LHX1+ renal vesicles that self-pattern into nephron structures. In both 2D and 3D culture, NPCs form kidney organoids containing epithelial nephron-like structures expressing markers of podocytes, proximal tubules, loops of Henle, and distal tubules in an organized, continuous arrangement that resembles the nephron in vivo. We also show that this organoid culture system can be used to study mechanisms of human kidney development and toxicity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

              Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapitulate tissue-specific epithelial physiology, including disease phenotypes after genome editing. In three-dimensional cultures, epiblast-stage hPSCs form spheroids surrounding hollow, amniotic-like cavities. GSK3β inhibition differentiates spheroids into segmented, nephron-like kidney organoids containing cell populations with characteristics of proximal tubules, podocytes and endothelium. Tubules accumulate dextran and methotrexate transport cargoes, and express kidney injury molecule-1 after nephrotoxic chemical injury. CRISPR/Cas9 knockout of podocalyxin causes junctional organization defects in podocyte-like cells. Knockout of the polycystic kidney disease genes PKD1 or PKD2 induces cyst formation from kidney tubules. All of these functional phenotypes are distinct from effects in epiblast spheroids, indicating that they are tissue specific. Our findings establish a reproducible, versatile three-dimensional framework for human epithelial disease modelling and regenerative medicine applications.
                Bookmark

                Author and article information

                Contributors
                marco.prunotto@roche.com
                periklis.pantazis@bsse.ethz.ch
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                3 November 2017
                3 November 2017
                2017
                : 7
                : 14490
                Affiliations
                [1 ]Department of Biosystems Science and Engineering (D-BSSE), Eidgenössische Technische Hochschule (ETH) Zurich, Mattenstrasse 26, 4058 Basel, Switzerland
                [2 ]Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, 4070 Basel, Switzerland
                [3 ]ISNI 0000 0004 1937 0650, GRID grid.7400.3, Institute for Regenerative Medicine (IREM), University of Zurich, Wagistrasse 12, ; 8952 Schlieren, Switzerland
                [4 ]ISNI 0000 0004 0478 9977, GRID grid.412004.3, Department of Surgical Research, University Hospital Zurich, Rämistrasse 100, ; 8091 Zurich, Switzerland
                [5 ]ISNI 0000 0004 0478 9977, GRID grid.412004.3, University Heart Center, University Hospital Zurich, Rämistrasse 100, ; 8091 Zurich, Switzerland
                [6 ]Wyss Translational Center Zurich, Moussonstrasse 13, 8044 Zurich, Switzerland
                [7 ]ISNI 0000 0001 0721 9812, GRID grid.150338.c, Department of Pathology, University Hospital of Geneva, ; Geneva, Switzerland
                [8 ]ISNI 0000 0004 1937 0650, GRID grid.7400.3, Present Address: Institute for Regenerative Medicine (IREM), Wyss Translational Center Zurich, University of Zurich, Wagistrasse 12, 8952, ; Schlieren, Switzerland
                Author information
                http://orcid.org/0000-0002-5189-541X
                http://orcid.org/0000-0003-4406-3508
                http://orcid.org/0000-0002-8367-9332
                Article
                12683
                10.1038/s41598-017-12683-y
                5670242
                29101326
                8f863f8d-ebc1-42f3-8ffb-cedf3cb5b6e5
                © The Author(s) 2017

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 6 June 2017
                : 14 September 2017
                Categories
                Article
                Custom metadata
                © The Author(s) 2017

                Uncategorized
                Uncategorized

                Comments

                Comment on this article